Intelligent Bio Solutions clears cybersecurity, software review items ahead of FDA 510(k) filing in H2 2026

Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS

0.00
  • Intelligent Bio Solutions cleared cybersecurity and software documentation items tied to its planned FDA 510(k) filing.
  • Submission remains slated for H2 2026, targeting initial clearance for codeine detection.
  • Penetration-test remediation reached 100% for medium-risk issues; low-risk items cut to 2 from 11.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607230830PRIMZONEFULLFEED9766877) on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.